{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:17:24Z","timestamp":1791602244993,"version":"4.3.4"},"reference-count":123,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Despite the vast amounts of research and remarkable discoveries that have been made in recent decades, cancer remains a leading cause of death and a major public health concern worldwide. Gossypol, a natural polyphenolic compound derived from the seeds, roots, and stems of cotton (Gossypium hirsutum L.), was first used as a male contraceptive agent. Due to its diverse biological properties, including antifertility, antiviral, antioxidant, antibacterial, antimalarial, and most notably antitumor activities, gossypol has been the subject of numerous studies. Nevertheless, no systematic review has been performed that analyzes the antineoplastic potential of gossypol and related natural compounds in an organ-specific manner while delineating the molecular mechanisms of action. Hence, we have performed an extensive literature search for anticancer properties of gossypol and their natural derivatives against various types of cancer cells utilizing PubMed, ScienceDirect, Google Scholar, and Scopus. The sources, distribution, chemical structure, and toxicity of gossypol and its constituents are briefly reviewed. Based on emerging evidence, gossypol and related compounds exhibit significant antineoplastic effects against various cancer types through the modulation of different cancer hallmarks and signaling pathways. Additionally, the synergistic activity of gossypol and its derivatives with chemotherapeutic agents has been observed. Our evaluation of the current literature suggests the potential of gossypol and its derivatives as multitargeting drug candidates to combat multiple human malignancies.<\/jats:p>","DOI":"10.3390\/pharmaceutics14122624","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T04:31:16Z","timestamp":1669609876000},"page":"2624","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9623-1617","authenticated-orcid":false,"given":"Dilipkumar","family":"Pal","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur 495 009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur 495 009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2468-4588","authenticated-orcid":false,"given":"Carly E.","family":"Wallace","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9159-960X","authenticated-orcid":false,"given":"Anupam","family":"Bishayee","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"ref_1","unstructured":"Agarwal, D.K., Singh, P., Chakrabarty, M., Shaikh, A.J., and Gayal, S.G. (2003). Cottonseed oil quality, utilization and processing. CICR Technic. Bull., 1\u201316. Available online: https:\/\/www.cicr.org.in\/pdf\/cottonseed_oil.pdf."},{"key":"ref_2","first-page":"200","article-title":"Cotton-seed oil: Its colouring matter and mucilage, and description of a new method of recovering the loss occurring in the refining process","volume":"5","author":"Longmore","year":"1886","journal-title":"J. Soc. Chem. Ind."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/prac.18990600108","article-title":"Gossypol, ein Bestandtheil der Baumwoll samen","volume":"60","author":"Marchlewski","year":"1899","journal-title":"J. Prakt. Chem."},{"key":"ref_4","first-page":"949","article-title":"(\u2212)-Gossypol-enriched cottonseed oil inhibits proliferation and adipogenesis of human breast pre-adipocytes","volume":"33","author":"Zhong","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_5","first-page":"123","article-title":"The effects of gossypol on spermatogenesis in NMRI mice","volume":"29","author":"Amini","year":"2005","journal-title":"Iran. J. Sci. Technol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/cr60208a002","article-title":"Gossypol, A pigment of cottonseed","volume":"60","author":"Adams","year":"1960","journal-title":"Chem. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/asj.12784","article-title":"Effect of radiation on chemical composition and protein quality of cottonseed meal","volume":"88","author":"Bahraini","year":"2017","journal-title":"Anim. Sci. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1038\/s41598-021-84970-8","article-title":"Gossypol decreased cell viability and down\u2014Regulated the expression of a number of genes in human colon cancer cells","volume":"11","author":"Cao","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1517\/13543784.14.11.1419","article-title":"Investigations on gossypol: Past and present developments","volume":"14","author":"Dodou","year":"2005","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.snb.2013.01.025","article-title":"Rapid detection assay for the molecular imprinting of gossypol using a two-layer PMAA\/SiO2 bulk structure with a piezoelectric imprinting sensor","volume":"181","author":"Zhao","year":"2013","journal-title":"Sens. Actuators B Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/aic.11700","article-title":"An improved ultrasound-assisted extraction process of Gossypol acetic acid from cottonseed soapstock","volume":"55","author":"Jia","year":"2009","journal-title":"AIChE J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0749-0720(15)30975-0","article-title":"Gossypol as a toxicant in livestock","volume":"5","author":"Morgan","year":"1989","journal-title":"Vet. Clin. N. Am. Food. Anim. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2605.1982.tb00304.x","article-title":"Gossypol","volume":"5","author":"Prasad","year":"1982","journal-title":"Int. J. Androl."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.pa.24.040184.001553","article-title":"Gossypol: A potential antifertility agent for males","volume":"24","author":"Qian","year":"1984","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2527\/1992.7051628x","article-title":"Effects of Gossy 01 and cottonseed products on reproduction of mammals","volume":"70","author":"Randel","year":"1992","journal-title":"J. Anim. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0010-7824(02)00294-9","article-title":"Gossypol: A contraceptive for men","volume":"65","author":"Coutinho","year":"2002","journal-title":"Contraception"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/13880209.2013.832776","article-title":"Therapeutic potential of gossypol: An overview","volume":"52","author":"Goliaei","year":"2014","journal-title":"Pharm. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2174\/0929867324666170523123655","article-title":"Natural product Gossypol and its derivatives in precision cancer medicine","volume":"26","author":"Zeng","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1039\/c39860000100","article-title":"The stereochemistry of the biosynthetic precursor of gossypol","volume":"2","author":"Stipanovic","year":"1986","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1043-4526(09)58006-0","article-title":"Chapter 6 Gossypol-A polyphenolic compound from cotton plant","volume":"58","author":"Wang","year":"2009","journal-title":"Adv. Food. Nutri. Res."},{"key":"ref_21","first-page":"1069","article-title":"Isolation of Gossypol from the bark of cotton roots","volume":"25","author":"Khaitbaev","year":"2021","journal-title":"Ann. Rom. Soc. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11746-006-1203-1","article-title":"Reaction chemistry of gossypol and its derivatives","volume":"83","author":"Kenar","year":"2006","journal-title":"J. Am. Oil Chem. Soc."},{"key":"ref_23","first-page":"125","article-title":"Physiological effects and metabolism of gossypol","volume":"61","author":"Mohamed","year":"1976","journal-title":"Residue Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"116333","DOI":"10.1016\/j.carbpol.2020.116333","article-title":"Synthesis, characterization and antioxidant activity of chitosan Schiff base derivatives bearing (\u2212)-gossypol","volume":"240","author":"Beyazit","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/chir.10171","article-title":"Determination of the absolute configuration and solution conformation of gossypol by vibrational circular dichroism","volume":"15","author":"Freedman","year":"2003","journal-title":"Chirality"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/jf049626p","article-title":"Determination of Gossypol enantiomer ratio in cotton plants by chiral higher-performance liquid chromatography","volume":"52","author":"Cass","year":"2004","journal-title":"J. Agric. Food. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1520-636X(1999)11:1<46::AID-CHIR8>3.0.CO;2-I","article-title":"First direct resolution of gossypol enantiomers on a chiral high-performance liquid chromatography phase","volume":"11","author":"Cass","year":"1999","journal-title":"Chirality"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/1535-7163.13.4.1","article-title":"Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X L [(\u00c0) -gossypol] against diffuse large cell lymphoma","volume":"4","author":"Mohammad","year":"2005","journal-title":"Mol. Can. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/chir.530040403","article-title":"Optical stability of gossypol","volume":"4","author":"Jaroszewski","year":"1992","journal-title":"Chirality"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/BF02912562","article-title":"Gossypol analysis in cottonseed oil by HPLC","volume":"65","author":"Chamkasem","year":"1988","journal-title":"J. Am. Oil Chem. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1081\/JLC-120003038","article-title":"Separation of multi-milligram quantities of gossypol enantiomers on polysaccharide-based stationary phases","volume":"25","author":"Cass","year":"2002","journal-title":"J. Liq. Chromatogr. Relat. Tec."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.carres.2011.06.031","article-title":"Novel O-glycosidic gossypol isomers and their bioactivities","volume":"346","author":"Yin","year":"2011","journal-title":"Carbohyd. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1039\/P29910001359","article-title":"Spectroscopic and kinetic studies of the aldehyde\u2014Lactol tautomerisation of gossypol in solution","volume":"2","author":"Marciniak","year":"1991","journal-title":"J. Chem. Soc. Perkin. Trans."},{"key":"ref_34","first-page":"2801","article-title":"A liposomal delivery vehicle for the anticancer agent Gossypol","volume":"28","author":"Zhai","year":"2008","journal-title":"Anticancer Res."},{"key":"ref_35","first-page":"320","article-title":"Gossypol: A potential promising anticancer agent","volume":"6","year":"2017","journal-title":"SAJP"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0165-1110(93)90021-E","article-title":"Genetic toxicity studies of gossypol","volume":"297","author":"Wang","year":"1993","journal-title":"Mutat. Res. Genet. Toxicol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2605.1998.00092.x","article-title":"Gossypol: Reasons for its failure to be accepted as a safe, reversible male antifertility drug","volume":"21","author":"Waites","year":"1998","journal-title":"Int. J. Androl."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"231635","DOI":"10.1155\/2014\/231635","article-title":"Gossypol Toxicity from Cottonseed Products","volume":"2014","author":"Gadelha","year":"2014","journal-title":"Sci. World. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-4274(00)00244-7","article-title":"Gossypol-induced DNA breaks in rat lymphocytes are secondary to cytotoxicity","volume":"117","author":"Quintana","year":"2000","journal-title":"Toxicol. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1010686204736","article-title":"Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I\/II clinical trial","volume":"66","author":"Poznak","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., G\u00f8tzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J., and Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS. Med., 6.","DOI":"10.2427\/5768"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1038\/cddis.2013.17","article-title":"The novel BH-3 mimetic apogossypolone induces Beclin-1-and ROS-mediated autophagy in human hepatocellular carcinoma cells","volume":"4","author":"Cheng","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0024-3205(95)00243-Y","article-title":"Antiproliferative activity of gossypol and gossypolone on human breast cancer cells","volume":"57","author":"Gilbert","year":"1995","journal-title":"Life Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/erc.1.01130","article-title":"Adrenocortical cancer: Pathophysiology and clinical management","volume":"14","author":"Libe","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40618-013-0049-2","article-title":"Management of adrenal cancer: A 2013 update","volume":"37","author":"Terzolo","year":"2014","journal-title":"J. Endocrinol. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S104366180200230X","article-title":"An In vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines","volume":"46","author":"Leblanc","year":"2002","journal-title":"Pharmacol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.phrs.2008.09.005","article-title":"(\u2212)-Gossypol promotes the apoptosis of bladder cancer cells In vitro","volume":"58","author":"Macoska","year":"2008","journal-title":"Pharmacol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00432-012-1187-1","article-title":"Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels","volume":"138","author":"Kisim","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_49","first-page":"113","article-title":"Induction of apoptosis by (-)-gossypol-enriched cottonseed oil in human breast cancer cells","volume":"26","author":"Ye","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejmech.2004.04.001","article-title":"Cytotoxicity of enantiomers of gossypol Schiff\u2019s bases and optical stability of gossypolone","volume":"39","author":"Dao","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1021\/jm1001698","article-title":"A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer","volume":"53","author":"Yan","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_52","first-page":"467","article-title":"Effects of gossypol on apoptosis\u2014Related gene expression in racially distinct triple\u2014Negative breast cancer cells","volume":"42","author":"Messeha","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.molonc.2015.03.014","article-title":"Natural product (\u2212)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1","volume":"9","author":"Lan","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0006-2952(03)00248-X","article-title":"Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells","volume":"66","author":"Zhang","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1000-1948(09)60049-6","article-title":"Inhibitory effect of a new gossypol derivative apogossypolone (ApoG2) on xenograft of human prostate cancer cell line PC-3","volume":"24","author":"Zhang","year":"2009","journal-title":"J. Med. Coll. PLA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopha.2012.10.016","article-title":"ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells","volume":"67","author":"Xin","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.canlet.2013.03.019","article-title":"ApoG2 induces ER stress-dependent apoptosis in gastric cancer cells In vitro and its real-time evaluation by bioluminescence imaging In vivo","volume":"336","author":"Xin","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1745-7254.2008.00901.x","article-title":"Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma","volume":"29","author":"Mi","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0223-5234(00)00165-3","article-title":"Synthesis and cytotoxicity of gossypol related compounds","volume":"35","author":"Dao","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1593\/neo.05691","article-title":"(\u2212)-Gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma In vivo","volume":"8","author":"Wolter","year":"2006","journal-title":"Neoplasia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1158\/1078-0432.CCR-04-0551","article-title":"In vitro effects of the BH3 Mimetic, (\u2212)-Gossypol, on head and neck squamous cell carcinoma cells","volume":"10","author":"Oliver","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/ijc.23752","article-title":"ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts","volume":"123","author":"Hu","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1186\/1479-5876-7-74","article-title":"ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway","volume":"7","author":"Hu","year":"2009","journal-title":"J. Transl. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.abb.2004.06.007","article-title":"Involvement of reactive oxygen species-independent mitochondrial pathway in gossypol-induced apoptosis","volume":"428","author":"Hou","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/1535-7163.23.4.1","article-title":"(\u2212)-Gossypol acts directly on the mitochondria to overcome Bcl-2-and Bcl-XLmediated apoptosis resistance","volume":"4","author":"Oliver","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_66","first-page":"870","article-title":"Gossypol induces apoptosis of multiple myeloma cells through the JUN-JNK pathway","volume":"10","author":"Zhang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_67","first-page":"773","article-title":"Valproic Acid Enhances the Anti-tumor Effect of (-)-gossypol to Burkitt Lymphoma Namalwa Cells","volume":"28","author":"Yi","year":"2015","journal-title":"Biomed. Environ. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3109\/10428194.2013.775437","article-title":"Natural Bcl-2 inhibitor (\u2212)-gossypol induces protective autophagy via reactive oxygen species\u2014High mobility group box 1 pathway in Burkitt lymphoma","volume":"54","author":"Ni","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.exphem.2008.01.003","article-title":"R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells","volume":"36","author":"Kline","year":"2008","journal-title":"Exp. Hematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-4598-7-20","article-title":"Preclinical studies of Apogossypolone: A new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-X L and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model","volume":"7","author":"Arnold","year":"2008","journal-title":"Mol. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/jf073297u","article-title":"Bioactivities of Gossypol, 6-Methoxygossypol, and 6,6\u2032-Dimethoxygossypol","volume":"56","author":"Wang","year":"2008","journal-title":"J. Agric. Food. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3389\/fphar.2018.00728","article-title":"Gossypol inhibits non-small cell lung cancer cells proliferation by Gossypol inhibits non-small cell lung cancer cells proliferation by targeting EGFRL858R\/T790M","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1021\/jm1001265","article-title":"BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma\/leukemia-2 (Bcl-2) family proteins","volume":"53","author":"Wei","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/aja.2009.87","article-title":"Inhibition of proliferation of prostate cancer cell line, PC-3, In vitro and In vivo using (\u2212)-gossypol","volume":"12","author":"Zhang","year":"2010","journal-title":"Asian J. Androl."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/1535-7163.MCT-08-0333","article-title":"Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa","volume":"7","author":"Meng","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_76","first-page":"2179","article-title":"(\u2212)-Gossypol reduces invasiveness in metastatic prostate cancer cells","volume":"29","author":"Huang","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_77","first-page":"69","article-title":"Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGF\u03b2\/Akt signaling","volume":"24","author":"Jiang","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1535-7163.197.4.2","article-title":"(\u2212)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer","volume":"4","author":"Xu","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_79","first-page":"1925","article-title":"Molecular mechanisms of (-)-Gossypol-induced apoptosis in human prostate cancer cells","volume":"26","author":"Huang","year":"2006","journal-title":"Anticancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s11033-009-9501-y","article-title":"Overcoming drug resistance in hormone-and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination","volume":"37","author":"Cengiz","year":"2010","journal-title":"Mol. Biol. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.lfs.2006.11.004","article-title":"Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways","volume":"80","author":"Zhang","year":"2007","journal-title":"Life Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/aja.2010.57","article-title":"Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells In vitro","volume":"12","author":"Zhang","year":"2010","journal-title":"Asian J. Androl."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","article-title":"Bladder cancer","volume":"374","author":"Kaufman","year":"2009","journal-title":"Lancet"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"ref_86","unstructured":"World Health Organization (2022, August 24). Breast Cancer. Updated 26 March 2021. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2231-4040.72251","article-title":"Various types and management of breast cancer: An overview","volume":"1","author":"Sharma","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.soc.2014.03.011","article-title":"Epidemiology of Breast Cancer","volume":"23","author":"Ban","year":"2014","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.7150\/ijbs.21635","article-title":"Risk Factors and Preventions of Breast Cancer","volume":"13","author":"Sun","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.critrevonc.2010.01.010","article-title":"Colon Cancer","volume":"74","author":"Labianca","year":"2010","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","article-title":"Gastric cancer","volume":"388","author":"Sagaert","year":"2016","journal-title":"Lancet"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1535-6108(02)00027-2","article-title":"Focus on lung cancer","volume":"1","author":"Minna","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood-2004-01-0037","article-title":"Advances in biology of multiple myeloma: Clinical applications","volume":"104","author":"Hideshima","year":"2004","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4065\/80.10.1371","article-title":"Multiple Myeloma: Diagnosis and Treatment","volume":"80","author":"Rajkumar","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"908","DOI":"10.6004\/jnccn.2009.0061","article-title":"Multiple myeloma","volume":"7","author":"Anderson","year":"2009","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.urology.2003.10.013","article-title":"Epidemiology of prostate cancer","volume":"62","author":"Crawford","year":"2003","journal-title":"Urology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","article-title":"Prostate cancer","volume":"8","author":"Mohler","year":"2010","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_101","first-page":"11","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb. Lab. Press"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World. J. Oncol."},{"key":"ref_103","first-page":"91","article-title":"The Inhibitory Effects of Gossypol on Human Prostate Cancer Cells-PC3 are Associated with Transforming Growth Factor Beta1 (TGF\u03b21) Signal Transduction Pathway","volume":"24","author":"Jiang","year":"2004","journal-title":"Anticancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1593\/neo.07778","article-title":"In Vivo Evaluation of AT-101 (R-(\u2013)-Gossypol acetic acid) in androgen-independent growth of VCaP prostate cancer cells in combination with surgical castration","volume":"9","author":"Loberg","year":"2007","journal-title":"Neoplasia"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12282-012-0372-z","article-title":"Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo","volume":"21","author":"Niu","year":"2014","journal-title":"Breast Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1535-7163.MCT-10-0936","article-title":"(\u2212)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis","volume":"10","author":"Pang","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1182\/blood-2007-09-113647","article-title":"Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048)","volume":"111","author":"Kitada","year":"2008","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2012.04.014","article-title":"Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage","volume":"47","author":"Zubair","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/ijms17060973","article-title":"Mobilization of intracellular copper by gossypol and apogossypolone leads to reactive oxygen species-mediated cell death: Putative anticancer mechanism","volume":"17","author":"Zubair","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/j.ejmech.2009.04.025","article-title":"Chiral gossypol derivatives: Evaluation of their anticancer activity and molecular modeling","volume":"44","author":"Zhang","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0968-0896(03)00066-X","article-title":"New thioderivatives of gossypol and gossypolone, as prodrugs of cytotoxic agents","volume":"11","author":"Dao","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/09553002.2016.1257833","article-title":"Injectable (-)-gossypol-loaded Pluronic P85 micelles for cancer chemoradiotherapy","volume":"93","author":"Tomoda","year":"2017","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1210\/en.2006-0502","article-title":"Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak","volume":"147","author":"Castilla","year":"2006","journal-title":"Endocrinol"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Wong, F.Y., Liem, N., Xie, C., Yan, F.L., Wong, W.C., Wang, L., and Yong, W.P. (2012). Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050786"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2012.12.005","article-title":"Poly(ethylene glycol)-block-poly(\u03b5-caprolactone) micelles for combination drug delivery: Evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer","volume":"166","author":"Cho","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Renner, O., Mayer, M., Leischner, C., Burkard, M., Berger, A., Lauer, U.M., Venturelli, S., and Bischoff, S.C. (2022). Systematic review of Gossypol\/AT-101 in cancer clinical trials. Pharmaceuticals, 15.","DOI":"10.3390\/ph15020144"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1136\/gutjnl-2020-321175","article-title":"Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma","volume":"70","author":"Song","year":"2021","journal-title":"Gut"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-08-2985","article-title":"An open-label, multicenter, phase I\/II study of single-agent AT-101 in men with castrate-resistant prostate cancer","volume":"15","author":"Liu","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10637-019-00797-1","article-title":"A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma","volume":"37","author":"Xie","year":"2019","journal-title":"Investig. New Drugs"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1097\/JTO.0b013e31822e2941","article-title":"A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer","volume":"6","author":"Baggstrom","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1006267902186","article-title":"Gossypol treatment of recurrent adult malignant gliomas","volume":"43","author":"Bushunow","year":"1999","journal-title":"J. Neuro-Oncol."},{"key":"ref_122","first-page":"1019","article-title":"Oral Gossypol in the treatment of metastatic adrenal cancer","volume":"76","author":"Flack","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00685601","article-title":"A preliminary clinical study of gossypol in advanced human cancer","volume":"30","author":"Stein","year":"1992","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/12\/2624\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:28:12Z","timestamp":1760146092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/12\/2624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":123,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["pharmaceutics14122624"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14122624","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}